Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors

Detalles Bibliográficos
Autores principales: Vici, Patrizia, Pizzuti, Laura, Krasniqi, Eriseld, Botticelli, Andrea, Ciliberto, Gennaro, Barba, Maddalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273903/
https://www.ncbi.nlm.nih.gov/pubmed/32489118
http://dx.doi.org/10.2217/imt-2020-0142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273903/
https://www.ncbi.nlm.nih.gov/pubmed/32489118
http://dx.doi.org/10.2217/imt-2020-0142

Ejemplares similares